e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Unusual pathogens in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors for multidrug resistant bacteria in Hospital-Acquired Pneumonia: A three-year cohort study
R. Seligman, L. Ramos-Lima, V. Oliveira, C. Sanvicente, E. Pacheco, J. Sartori, M. Fernandes, Jr. (Porto Alegre, Brazil)
Source:
Annual Congress 2010 - Unusual pathogens in respiratory infections
Session:
Unusual pathogens in respiratory infections
Session type:
Thematic Poster Session
Number:
2918
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Seligman, L. Ramos-Lima, V. Oliveira, C. Sanvicente, E. Pacheco, J. Sartori, M. Fernandes, Jr. (Porto Alegre, Brazil). Risk factors for multidrug resistant bacteria in Hospital-Acquired Pneumonia: A three-year cohort study. Eur Respir J 2010; 36: Suppl. 54, 2918
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
A multicenter study of antimicrobial resistance of clinical strains of pneumococci in Kyrgyzstan
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Burden and risk factors for
Pseudomonas aeruginosa
community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017
Year: 2018
Empiric penicillin monotherapy of CAP is not associated with increased mortality; experiences from the retrospective CAP-North cohort
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Predictive factors for multidrug-resistant pathogens in hemodialysis patients with pneumonia : a multicenter study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
Risk factors for multi-drug resistant TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Risk factors of pneumocytis pneumoniae in solid tumours: A case-control study
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia in Portuguese Adults: A single-center retrospective study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Dynamic of resistance of streptococcus pneumoniae strains from patients with CAP in theritary tertyary hospital: 10 years prospective study
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Early Rehospitalizations for Pneumonia: Incidence and Predictors in an Italian population-based cohort study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Risk of recurrence after surviving severe sepsis: A matched cohort study
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Frequency of multidrug resistant pathogens in healthcare associated pneumonia
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Risk factors for anti-TB drug resistance in Poland
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Low frequency of resistant pathogens in nursing home acquired pneumonia: A prospective study and systematic review
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
Relation between the empiric initial therapy of
S.pneumoniae
community-acquired pneumonia (SP-CAP) and mortality in thirty days of outcome. On behalf of Pneumococcal Pneumonia Cooperative Study Group, Grupo TIR, SEPAR
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept